Beigelman Leonid
Insider CIK 1824721 · ALGS President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-03-15 | 2023-03-17 | 169,500 | — | $0 | 169,500 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-07-07 | 2022-07-11 | 113,000 | — | $0 | 113,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 226,800 | — | $0 | 226,800 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 56,700 | — | $0 | 56,700 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2020-12-01 | 2020-12-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 1,437 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 21,724 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 3,359 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 3,359 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 50,781 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 13,559 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 13,559 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 163,842 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 1,437 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 1,437 | — | $0 | 18,355 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 21,724 | — | $0 | 236,347 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 1,437 | — | $0 | 18,355 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 3,359 | — | $0 | 16,918 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 3,359 | — | $0 | 16,918 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 50,781 | — | $0 | 214,623 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 13,559 | — | $0 | 13,559 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 13,559 | — | $0 | 13,559 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 163,842 | — | $0 | 163,842 | SEC↗ |